Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

GW Pharmaceuticals strengthens research and development team

Appoints Dr Volker Knappertz and Professor Ben Whalley

Bayer symbol

Bayer’s lymphoma drug copanlisib gets speedy FDA review

The PI3K inhibitor will be assessed for relapsed or refractory follicular lymphoma

- PMLiVE

Ionis says rare disease drug works, but safety concerns linger

Inotersen has been linked to cases of thrombocytopenia

The three forces behind the re-imagining of patient care

Understanding patient-centricity

- PMLiVE

Are you suffering from templatitis?

At times, it feels like procedures are designed to frustrate, and templates often hinder rather than help. Especially in strategic planning, where a certain degree of creativity and innovation is...

Lucid Group Communications Limited

- PMLiVE

J&J’s Jane Griffiths named global head of Actelion

Appointment will effect once Swiss biotech's acquisition is completed

Biogen Idec building

Biogen hands out $120m upfront for Remedy stroke drug

Cirara vying to be first new treatment since the 1990s

EU flag

EU starts investigation of Aspen’s cancer drug pricing

Amid reports of price increases of several hundred per cent

- PMLiVE

Finding a cure for ‘templatitis’…

It's time to stand together against this scourge of the industry

What’s next after e-detailing?

You have your e-detailing system in place and are now thinking about multichannel. You want to provide a seamless customer experience across all channels – websites, apps, social media platforms,...

Anthill Agency

Eli Lilly HQ

Lilly set to head to regulators with CGRP migraine drug

Gathers three positive late-stage trials of galcanezumab as it chases Amgen

AstraZeneca AZ

AZ buoyed by Imfinzi lung cancer trial

Phase III study shows PD-L1 inhibitor increased progression-free survival

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links